At Oak HC/FT, we look for founders who are not just building tools, but are reimagining the core infrastructure of healthcare to ensure that clinical breakthroughs actually reach the people who need them. While the life sciences sector has made major strides in drug discovery, the commercial systems responsible for managing the specialty patient journey have too often remained stuck in the past, relying on generic software and siloed data. Courier Health was founded to help solve this very challenge, and we are proud to announce our lead investment in their $50 million Series B round.
For patients navigating rare or chronic conditions, receiving a prescription is not the end of the journey, it is just the beginning of a long and often frustrating process. Insurance authorizations, specialty pharmacy coordination, nursing support, and administration challenges pose meaningful hurdles on the path to starting a life-altering therapy.
Historically, biopharma companies have attempted to manage this complexity with spreadsheets or general-purpose CRMs, systems architected for enterprise sales pipelines, not the nuanced, high-stakes work of coordinating and orchestrating across the patient journey. The result is information scattered across platforms, patient access and support teams buried in manual tasks, and little to no visibility over the end-to-end patient journey. Worst of all, patients and their loved ones suffer, with more than 30% of prescribed patients never starting treatment and nearly 70% discontinuing at the 12-month mark.
Courier Health is solving this by providing a dedicated command center purpose-built to power dynamic, complex patient journeys. Its platform is built to connect data, apply rich intelligence, and orchestrate across manufacturers, pharmacies, payers, healthcare providers and organizations, with several unique elements that set their technology apart:
- A Native Healthcare Data Model: Unlike standard business software that treats patients like generic “objects”, Courier Health’s patient-centric system is built specifically for life sciences, including understanding the relationships, nuances, and complexities between patients, providers, various insurance providers, and more.
- Context-rich AI: The system leverages patient journey data captured and generated in the platform to surface insights, predict risks, and automate next best actions, so biopharma teams spend more time problem-solving and driving quality patient and provider interactions.
- Intuitive UI: The platform is designed specifically for market access and patient services teams day-to-day workflows, with a growing list of agentic capabilities that can execute key tasks for reliable automation and scale.
Biopharma companies utilizing Courier Health have seen 15-20% increases in patient starts, 10-12% increases in 6-month persistency rates, and 5-7-fold increases in team productivity. Most importantly, this means that patients can get faster, more tailored access to game-changing medicines.
Behind this is a founder worth betting on. Danny Sigurdson, Courier's CEO, brings rare depth from his tenures at Dayforce, ActionIQ and Applied Predictive Technologies, and a learning velocity that sets him apart. His immersion in the biopharma ecosystem has produced a product that earns trust from early-stage biotechs and global pharmaceutical manufacturers alike. In 2025 alone, Courier quadrupled the number of treatments supported on its platform.
Our partnership with Courier Health is rooted in a shared belief that technology should make life-saving medicine easier to access, not harder. We are grateful for the opportunity to work alongside Danny and the entire team as they scale their mission to redefine the patient experience for hundreds of millions of people.